JOSHUA MINGA: Open Payments
NPI 1184080640 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 15 payments from 7 companies in 2025. Trend: 2023 $166 · 2024 $570 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 8 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Philips North America LLC | 1 | $22 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
| Grifols USA, LLC | 1 | $16 |
Products named: INSPIRE, GLASSIA, ULTOMIRIS, ZERBAXA, Vest Therapy Und, Xeomin, Prolastin-C Liquid.
Industry payments across MS — which companies pay providers there.
